There have been
huge advancements in technology, in the last few years, in terms of providing
top-notch diagnostics options for proper management of organ transplants, which
in turn has driven the transplant diagnostics market in more than one way. The
market has also procured the attention of healthcare providers due to an array
of benefits offered by these tests to gauge the viability of the organ
transplant method. The market is already in an established state in the
developed economies, while the developing provinces such as Asia-Pacific and
LAMEA hold prospective opportunities for transplant diagnostics.
According to
Allied Market Research, the global Singapore transplant diagnostics market is anticipated to display a significant CAGR from 2014 to
2022. Rising geriatric population has led to a steep increase in the number of
transplantations, as these measures are highly required for people, especially
for those above 60 years, due to the prevalence of chronic diseases in them. Rising
awareness among individuals related to the significance of organ
transplantation has become an ongoing drift in the European nations. This,
accordingly, has given way to huge number of organ donations specifically from
living donors.
A renowned name in transplantation diagnostics, Immucor, Inc., has come up with two more add-ons to its transplant diagnostics range, validating their ongoing obligation to novel advancements in the sphere of histocompatibility.
The EXPRESS HLA typing software is designed to give users a faster NGS analysis experience at ease. The MIA FORA NGS EXPRESS would also provide the cost-efficient choice of a typical desktop computing solution along with the existing Linux server.
The software remains the first NGS HLA inquiry way out that takes recourse three algorithms for the examination of phenotyping calls and a patented solution for accurate mapping and configuration. Immucor has also proclaimed that LIFECODES® LSATM Class I and Class II Assays, the single antigen product has also grabbed the mandatory FDA clearance in the USA.
Request for Sample Report for
More Insights @ https://www.alliedmarketresearch.com/request-sample/1135
Top Leading Players:
· Abbott Laboratories Inc.
· Bio-Rad Laboratories Inc.
· F. Hoffmann-La Roche, Ltd.
· Illumina, Inc.
· Immucor, Inc.
· Linkage Biosciences
· Olerup Ssp Ab
· Qiagen N.V.
· Thermo Fisher Scientific Inc
Covid-19 Scenario-
Here,
it’s worth mentioning that the outbreak of the Covid-19 pandemic gave way to adjournment
of the majority of elective surgeries across the world, which in turn resulted
into a steep decline in demand for transplant diagnostics, thereby impacting
the market negatively, especially during the initial period. However, as the
global situation is getting back to normalcy, the market is also projected to
revive soon.
0 Comments